347 related articles for article (PubMed ID: 24351716)
21. Acetylcholine-Binding Protein Affinity Profiling of Neurotoxins in Snake Venoms with Parallel Toxin Identification.
Palermo G; Schouten WM; Alonso LL; Ulens C; Kool J; Slagboom J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069093
[TBL] [Abstract][Full Text] [Related]
22. The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming.
Gutiérrez JM; Albulescu LO; Clare RH; Casewell NR; Abd El-Aziz TM; Escalante T; Rucavado A
Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34209691
[TBL] [Abstract][Full Text] [Related]
23. Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways.
Bickler PE
Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31979014
[TBL] [Abstract][Full Text] [Related]
24. Differential myotoxic and cytotoxic activities of pre-synaptic neurotoxins from Papuan taipan (Oxyuranus scutellatus) and Irian Jayan death adder (Acanthophis rugosus) venoms.
Chaisakul J; Parkington HC; Isbister GK; Konstantakopoulos N; Hodgson WC
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):325-34. PubMed ID: 23311944
[TBL] [Abstract][Full Text] [Related]
25. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
Offor BC; Muller B; Piater LA
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
[TBL] [Abstract][Full Text] [Related]
26. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B
Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430
[TBL] [Abstract][Full Text] [Related]
27. Snake three-finger α-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine.
Nirthanan S
Biochem Pharmacol; 2020 Nov; 181():114168. PubMed ID: 32710970
[TBL] [Abstract][Full Text] [Related]
28. Synergistic strategies of predominant toxins in snake venoms.
Xiong S; Huang C
Toxicol Lett; 2018 May; 287():142-154. PubMed ID: 29428543
[TBL] [Abstract][Full Text] [Related]
29. Lys49 myotoxins, secreted phospholipase A
Lomonte B
Toxicon; 2023 Mar; 224():107024. PubMed ID: 36632869
[TBL] [Abstract][Full Text] [Related]
30. Neurotoxic effects of venoms from seven species of Australasian black snakes (Pseudechis): efficacy of black and tiger snake antivenoms.
Ramasamy S; Fry BG; Hodgson WC
Clin Exp Pharmacol Physiol; 2005; 32(1-2):7-12. PubMed ID: 15730427
[TBL] [Abstract][Full Text] [Related]
31. Anti-Neurotoxins from
Cardona-Ruda A; Rey-Suárez P; Núñez V
Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448874
[TBL] [Abstract][Full Text] [Related]
32. The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle.
Fatehi M; Rowan EG; Harvey AL; Harris JB
Toxicon; 1994 Dec; 32(12):1559-72. PubMed ID: 7725325
[TBL] [Abstract][Full Text] [Related]
33. Widespread Evolution of Molecular Resistance to Snake Venom α-Neurotoxins in Vertebrates.
Khan MA; Dashevsky D; Kerkkamp H; Kordiš D; de Bakker MAG; Wouters R; van Thiel J; Op den Brouw B; Vonk F; Kini RM; Nazir J; Fry BG; Richardson MK
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023159
[TBL] [Abstract][Full Text] [Related]
34. Structure-function relationships of phospholipases. II: Charge density distribution and the myotoxicity of presynaptically neurotoxic phospholipases.
Kini RM; Iwanaga S
Toxicon; 1986; 24(9):895-905. PubMed ID: 3544338
[TBL] [Abstract][Full Text] [Related]
35. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A
Sørensen CV; Almeida JR; Bohn MF; Rivera-de-Torre E; Schoffelen S; Voldborg BG; Ljungars A; Vaiyapuri S; Laustsen AH
Toxicon; 2023 Oct; 234():107307. PubMed ID: 37783315
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro.
Lomonte B; Angulo Y; Rufini S; Cho W; Giglio JR; Ohno M; Daniele JJ; Geoghegan P; Gutiérrez JM
Toxicon; 1999 Jan; 37(1):145-58. PubMed ID: 9920486
[TBL] [Abstract][Full Text] [Related]
38. Bites and stings from venomous animals: a global overview.
White J
Ther Drug Monit; 2000 Feb; 22(1):65-8. PubMed ID: 10688262
[TBL] [Abstract][Full Text] [Related]
39. The effects of snake venoms and their neurotoxins on the nervous system of man and animals.
Campbell CH
Contemp Neurol Ser; 1975; 12():259-93. PubMed ID: 124647
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation.
Ramasamy S; Isbister GK; Hodgson WC
Toxicon; 2004 Dec; 44(8):837-45. PubMed ID: 15530965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
